Liminal BioSciences Inc.
Liminal BioSciences Inc. (LMNL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lmnl · stock forecast · 2 analysts (3M) · FMP · updated Nov 15, 2024
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Hold
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $8.50
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $8.49 | ↓ 0.08% |
1-day model range: $8.49–$8.5. Peak: $8.5 (-0.08%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LMNL · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-06-24 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2021-06-02 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2021-02-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2020-12-21 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Liminal BioSciences Inc. (LMNL) stock. Of the recent 4 rating actions, 0 were upgrades and 2 were downgrades. 2 analysts currently cover LMNL.
Analyst Recommendation Trends
LMNL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast LMNL EPS of $— for the current fiscal year, based on estimates from 0 analysts. The LMNL revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LMNL stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LMNL price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The LMNL short-term stock prediction for tomorrow is $8.49 (-0.08%).
Liminal BioSciences Inc. trades on NASDAQ under the ticker LMNL. The LMNL stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
LMNL forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month LMNL price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $8.50.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.